Q4 2013 Holdings
Filed 2014-02-14 | 95 holdings | $752.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $498.7M | 19,955,126 | 66.3% |
| Biomarin Pharmaceuticals(BMRN) | COM | 09061G101 | $136.6M | 1,941,304 | 18.2% |
| Cerus(CERS) | COM | 157085101 | $54.5M | 8,455,306 | 7.3% |
| Biocryst Pharmaceuticals Inc.(BCRX) | COM | 09058V103 | $50.9M | 6,699,979 | 6.8% |
| Agios Pharmaceuticals(AGIO) | COM | 00847X104 | $4.9M | 205,750 | 0.7% |
| Pharmacyclics Inc. | COM | 716933106 | $922.3K | 8,719,218 | 0.1% |
| Seattle Genetics Inc. | COM | 812578102 | $827.2K | 20,735,926 | 0.1% |
| Incyte Corp.(INCY) | COM | 45337C102 | $749.9K | 14,810,559 | 0.1% |
| Synageva Biopharma Corp. | COM | 87159A103 | $664.9K | 10,273,182 | 0.1% |
| Salix 2.75% 5/15/15 | CONV BONDS | 795435AC0 | $431.7K | $219,440,000 | 0.1% |
| Genomic Health Inc.(GHDX) | COM | 37244C101 | $399.6K | 13,650,835 | 0.1% |
| Incyte Genomics Notes 1.25% 11/15/2020 144A | CONV BONDS | 45337CAL6 | $333.0K | $274,500,000 | 0.0% |
| Incyte Genomics Notes 0.375% 11/15/2018 144A | CONV BONDS | 45337CAK8 | $310.0K | $259,000,000 | 0.0% |
| Incyte Genomics Notes 4.75% 10/1/2015 144A | CONV BONDS | 45337CAH5 | $233.0K | $40,446,000 | 0.0% |
| Xoma Corp. | COM | 98419J107 | $155.0K | 23,032,372 | 0.0% |
| Auxilium 1.5% 7/15/2018 | CONV BONDS | 05334DAA5 | $96.3K | $87,090,000 | 0.0% |
| Halozyme Therapeutics Inc.(HALO) | COM | 40637H109 | $94.4K | 6,297,026 | 0.0% |
| Biomarin Pharmaceuticals Notes 1.875% 4/23/2017 | CONV BONDS | 09061GAD3 | $79.4K | $22,898,000 | 0.0% |
| Gilead 1.625% 5/1/16 | CONV BONDS | 375558AP8 | $70.9K | $21,500,000 | 0.0% |
| Vanda Pharmaceuticals, Inc.(VNDA) | COM | 921659108 | $59.5K | 4,791,179 | 0.0% |
| Medivation 2.625% 4/1/17 | CONV BONDS | 58501NAA9 | $57.8K | $39,500,000 | 0.0% |
| Intermune Inc Notes 2.5% 12/15/17 | CONV BONDS | 45884XAF0 | $56.2K | $41,000,000 | 0.0% |
| Repros Therapeutics | COM | 76028H209 | $50.8K | 2,778,654 | 0.0% |
| Questcor Pharmaceuticals, Inc. | COM | 74835Y101 | $42.2K | 775,864 | 0.0% |
| Anacor Pharmaceuticals | COM | 032420101 | $42.0K | 2,500,000 | 0.0% |
| Gilead Sciences Inc.(GILD) | COM | 375558103 | $41.8K | 556,108 | 0.0% |
| Mirati Therapeutics Inc.(MRTXEUR) | COM | 60468T105 | $39.6K | 2,380,074 | 0.0% |
| Aegerion Pharmaceuticals | COM | 00767E102 | $35.5K | 500,000 | 0.0% |
| Arrowhead Research Corp. | COM | 042797209 | $33.5K | 3,090,000 | 0.0% |
| Clovis Oncology(CLVSEUR) | COM | 189464100 | $32.0K | 530,738 | 0.0% |
| Derma Sciences | COM | 249827502 | $27.7K | 2,558,857 | 0.0% |
| Chelsea Therapeutics | COM | 163428105 | $25.7K | 5,794,753 | 0.0% |
| Medivation Inc. | COM | 58501N101 | $25.4K | 398,331 | 0.0% |
| Intercept Pharmaceuticals, Inc.(ICPTUSD) | COM | 45845P108 | $24.8K | 362,847 | 0.0% |
| Progenics Pharmaceuticals, Inc. | COM | 743187106 | $22.4K | 4,200,000 | 0.0% |
| Salix 1.5% 3/15/19 | CONV BONDS | 795435AE6 | $22.4K | $15,000,000 | 0.0% |
| Intermune Inc Notes 5% 3/1/15 | CONV BONDS | 45884XAD5 | $19.5K | $16,860,000 | 0.0% |
| Avanir Pharmaceuticals | COM Class A | 05348P401 | $18.2K | 5,428,591 | 0.0% |
| Dyax Corp. | COM | 26746E103 | $15.3K | 2,026,537 | 0.0% |
| Idera Pharmaceuticals Inc. | COM | 45168K306 | $14.7K | 3,171,765 | 0.0% |
| Synergy Pharmaceuticals | COM | 871639308 | $14.7K | 2,608,271 | 0.0% |
| Insmed Inc.(INSM) | COM | 457669307 | $13.5K | 796,378 | 0.0% |
| Biomarin Pharmaceuticals Notes 0.75% 10/15/2018 | CONV BONDS | 09061GAE1 | $13.3K | $12,500,000 | 0.0% |
| Stemline Therapeutics Inc. | COM | 85858C107 | $13.2K | 675,042 | 0.0% |
| Kythera Biopharmaceuticals | COM | 501570105 | $11.7K | 313,191 | 0.0% |
| Isis Pharmaceuticals | COM | 464330109 | $9.8K | 247,036 | 0.0% |
| Zogenix, Inc. | COM | 98978L105 | $9.5K | 2,751,000 | 0.0% |
| Prothena Corp. PLC(PRTA) | SHS | G72800108 | $8.9K | 336,918 | 0.0% |
| Infinity Pharmaceuticals Inc. | COM | 45665303 | $8.9K | 643,256 | 0.0% |
| Threshold Pharma | COM | 885807206 | $8.7K | 1,852,399 | 0.0% |